Menopausal hormone therapy in relation to breast cancer characteristics and prognosis: a cohort study
about
Menopausal hormone therapy and breast cancer mortality: clinical implicationsAge-related variation in the relationship between menopausal hormone therapy and the risk of dying from breast cancerBreast cancer tumour growth modelling for studying the association of body size with tumour growth rate and symptomatic detection using case-control data.Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational StudyHormone Therapy and its Effect on the Prognosis in Breast Cancer Patients.Changing concepts: Menopausal hormone therapy and breast cancer.Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trialMammographic density reduction is a prognostic marker of response to adjuvant tamoxifen therapy in postmenopausal patients with breast cancer.The influence of menopausal hormone therapy on tumour characteristics and survival in endometrial cancer patients.Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women.Reproductive risk factors and oestrogen/progesterone receptor-negative breast cancer in the Breast Cancer Family Registry.Hormone replacement therapy and breast cancer survival: a systematic review and meta-analysis of observational studies.Relationship between menopausal hormone therapy and mortality after breast cancer The MARIEplus study, a prospective case cohort.A statistical model of breast cancer tumour growth with estimation of screening sensitivity as a function of mammographic density.Family history influences the tumor characteristics and prognosis of breast cancers developing during postmenopausal hormone therapy.Modelling breast cancer tumour growth for a stable disease population.The influence of mammographic density on breast tumor characteristicsGenetic variation in the androgen estrogen conversion pathway in relation to breast cancer prognosticators
P2860
Q27022201-DBEB2583-8D64-4ABA-A12C-0FF82BA5CF12Q30498819-45296918-CE43-4330-B36F-F94032042BD6Q30988479-C40F8654-CB3D-47D5-A5BB-BF62A5CC5727Q34336219-F10CBBC6-9CFF-4D9D-950D-10DD0F46B98DQ35815464-48F40CE6-2888-4703-9C41-7931E9F6B0F3Q35866374-50BE8B8F-9BC8-4B25-BD6F-B9F577E98DD3Q36143058-707D8493-75D0-4A1D-84F5-C8ECA2854CE3Q36916765-BDCDD77F-8764-4FF2-91C8-E96B1C8B9D07Q37438166-BF62A3E6-B59F-42A1-93B4-9F123A2F2FFFQ37480990-979808EC-74C6-4BB0-A22D-42F289BEC2F7Q37632099-A3AF7408-5E82-4F51-BCB2-A9D8DF110862Q39364630-17085643-D199-4F12-B4B7-F531D4450644Q41065061-89FFA3EB-046D-4AFE-8799-5CCCEC9A7984Q46116445-D47C3D67-E366-43A9-A1D1-D970FC265107Q48212258-1CD94467-2232-44CB-91CC-DD773863EAFDQ48364755-21E4D54B-C489-44AC-8D75-F79D37D5E95AQ57568288-9180AACF-E8CE-4356-87BE-141B27E87EF3Q57568320-DD93FDE8-CDDC-4DA8-8213-9B64225B1412
P2860
Menopausal hormone therapy in relation to breast cancer characteristics and prognosis: a cohort study
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Menopausal hormone therapy in ...... and prognosis: a cohort study
@en
Menopausal hormone therapy in ...... and prognosis: a cohort study.
@nl
type
label
Menopausal hormone therapy in ...... and prognosis: a cohort study
@en
Menopausal hormone therapy in ...... and prognosis: a cohort study.
@nl
prefLabel
Menopausal hormone therapy in ...... and prognosis: a cohort study
@en
Menopausal hormone therapy in ...... and prognosis: a cohort study.
@nl
P2093
P2860
P50
P356
P1476
Menopausal hormone therapy in ...... and prognosis: a cohort study
@en
P2093
Fredrik Granath
Ingemar Persson
Lena U Rosenberg
Sara Wedrén
P2860
P2888
P356
10.1186/BCR2145
P577
2008-09-19T00:00:00Z
P5875
P6179
1015583909